None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients undergoing elective laparoscopic hysterectomy; 2.United States American Society of Anes-thesiologists (ASA) class I-II; 3.Body mass index (BMI) >=20 and <= 35 kg/m^2; 4.Normal laboratory indicators such as liver function, kidney function, and coagulation function; 5.Able to cooperate well with postoperative resting, exercise and visceral pain scores; Able to properly use an intravenous self-controlled analgesic pump under the guidance of a nurse.
Exclusion criteria
Exclusion criteria: 1.Patients with cognitive dysfunction before and after surgery, who are unable to cooperate in pain assessment; 2.Patients with severe mental disorders; 3.Patients with severe cardiovascular and cerebrovascular diseases such as unstable angina pectoris, severe arrhythmia, severe valvular heart disease, cerebral infarction, etc.; 4.Patients with abnormal liver or kidney function, coagulation disorders, or blood system infections; 5.Patients with infection or tumor lesions at the puncture site; 6.Patients in shock; 7.Patients allergic to local anesthetics; 8.Patients have severe spinal deformities.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hydromorphone consumption in the first 12 hours after surgery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Visual analogue scale (at rest and during exercise);Mean arterial pressure ;Inflammatory markers (IL-6, IL-10, TNF-a);Bruggrmann comfort sealed,BCS;The time of the first self-controlled use of the analgesic pump after surgery;The total dose of hydromorphone used.;Perioperative adverse reactions;Heart rate; | — |
Countries
China
Contacts
Mindong Hospital of Ningde(Mindong Hospital Affiliated to Fujian Medical University)